Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now...watched for heart failure
December 2001
Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now need to be watched for heart failure.
This is because of a higher incidence of mortality and worsening heart failure when Remicade is given to patients with moderate to severe heart failure.
This is a surprise.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote